ARTICLE | Finance
Amgen's preemptive strike
Amgen opening bid may have dissuaded competing offers for Onyx
September 2, 2013 7:00 AM UTC
Buysiders say Amgen Inc.'s aggressive opening offer for Onyx Pharmaceuticals Inc. may have dissuaded other would-be suitors from entering into a bidding war.
On Aug. 25 the companies agreed to a purchase price of $125 per share in cash, or about $10.4 billion...